What smart money is saying about Cipher Pharmaceuticals
CPH.TO
No fund has written a full thesis on Cipher Pharmaceuticals in our archive, but 1 fund letter reports a position in it — most recently Donville Kent Capital Ideas Fund LP in June 2026.
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Cipher Pharmaceuticals on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- June 2026
“Cipher is now Net Cash ($6.4M) after paying back all of the debt used to fund the Natroba acquisition.”
Read the letterCipher Pharmaceuticals
Read the letters behind these Cipher Pharmaceuticals positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger